Your browser doesn't support javascript.
COVID-19 and Subsequent Development of Pancytopenia With Concurrent Disseminated Intravascular Coagulation.
Dube, Michael D; Sapkota, Sumina; Lakhatariya, Khushboo; Russo, Anthony.
  • Dube MD; College of Medicine, Northeast Ohio Medical University, Rootstown, USA.
  • Sapkota S; Department of Internal Medicine, Trumbull Regional Medical Center, Warren, USA.
  • Lakhatariya K; Department of Internal Medicine, Trumbull Regional Medical Center, Warren, USA.
  • Russo A; Department of Internal Medicine, Trumbull Regional Medical Center, Warren, USA.
Cureus ; 14(12): e32845, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-2217549
ABSTRACT
Complications resulting from coronavirus disease 2019 (COVID-19) sequelae have been well documented. These include blood conditions such as lymphopenia, thrombocytopenia, and hypercoagulability. Less common problems that may arise are disseminated intravascular coagulation (DIC), immune thrombocytopenic purpura (ITP), and pancytopenia. Furthermore, the majority of COVID-19 patients to develop pancytopenia have been immunosuppressed. We present a case of a previously immunocompetent patient who subsequently developed pancytopenia, DIC, as well as symptoms of ITP one month after being diagnosed with COVID-19.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Topics: Long Covid Language: English Journal: Cureus Year: 2022 Document Type: Article Affiliation country: Cureus.32845

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report Topics: Long Covid Language: English Journal: Cureus Year: 2022 Document Type: Article Affiliation country: Cureus.32845